Kalwant Authi

Dr. Kalwant Authi


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2007
Verified
Book Chapter
Closed access
PDF file
KAKalwant Authi
Kalwant Authi

1 March 2014 in Cellular Signalling
Verified
Journal Article
Open access
AAA. Ambily
A. Ambily
WKW.J. Kaiser
W.J. Kaiser
CPC. Pierro
C. Pierro
ECE.V. Chamberlain
E.V. Chamberlain
ZLZ. Li
Z. Li
KAKalwant Authi
Kalwant Authi
Ca(2+) elevation is essential to platelet activation. STIM1 senses Ca(2+) in the endoplasmic reticulum and activates Orai channels allowing store-operated Ca(2+) entry (SOCE). STIM1 has also been reported to be present in the plasma membrane (PM) with its N-terminal region exposed to the outside medium but its role is not fully understood. We have examined the effects of the antibody GOK/STIM1, which recognises the N-terminal region of STIM1, on SOCE, agonist-stimulated Ca(2+) entry, surface exposure, in vitro thrombus formation and aggregation in human platelets. We also determined novel binding partners of STIM1 using proteomics. The dialysed GOK/STIM1 antibody failed to reduced thapsigargin- and agonist-mediated Ca(2+) entry in Fura2-labelled cells. Using flow cytometry we detect a portion of STIM1 to be surface-exposed. The dialysed GOK/STIM1 antibody reduced thrombus formation by whole blood on collagen-coated capillaries under flow and platelet aggregation induced by collagen. In immunoprecipitation experiments followed by proteomic analysis, STIM1 was found to extract a number of proteins including myosin, DOCK10, thrombospondin-1 and actin. These studies suggest that PM STIM1 may facilitate platelet activation by collagen through novel interactions at the plasma membrane while the essential Ca(2+)-sensing role of STIM1 is served by the protein in the ER.

1 December 2002 in Blood
Verified
Journal Article
Open access
PDF file
SSStewart O. Sage
Stewart O. Sage
SBSharon L. Brownlow
Sharon L. Brownlow
Juan Antonio RosadoJuan Antonio Rosado
Juan Antonio Rosado
KAKalwant Authi
Kalwant Authi
SHSheila Hassock
Sheila Hassock
CTClaudia Trost
Claudia Trost

1 July 2015 in Cellular Signalling
Verified
Journal Article
Closed access
NKNick Kassouf
Nick Kassouf
AAArchana Ambily
Archana Ambily
SWStephanie Watson
Stephanie Watson
SHSheila Hassock
Sheila Hassock
HAHarmeet S. Authi
Harmeet S. Authi
KAKalwant Authi
Kalwant Authi

7 August 2025 in Cells
Verified
Journal Article
Open access
PDF file
QXQi Xu
Qi Xu
YOYaw Nana Opoku
Yaw Nana Opoku
KAKalwant Authi
Kalwant Authi
ACAgostino Cilibrizzi
Agostino Cilibrizzi
Ischemic heart disease (IHD) represents a leading cause of global morbidity and mortality. Despite significant advances in treatment achieved over recent decades, as well as various therapeutic strategies available to manage IHD progression currently, the global incidence of this disorder remains high. This review examines essential cell biology aspects of adenosine receptors (ARs), along with the effects of known synthetic small-molecule AR ligands, to provide an up-to-date view on the therapeutic potential towards IHD treatment. In particular, we report here advancements made on a selection of AR synthetic ligands that have demonstrated efficacy in pre-clinical or clinical studies, thereby holding promise as new therapeutic candidates in the field of IHD. Although this work adds further evidence that clinically valid small-molecule therapeutic agents targeting ARs exist, their use represents an emerging area, with most drug prototypes still in the pre-clinical developmental stage and many lacking large-scale clinical trials. The future lies in identifying improved AR synthetic ligands with enhanced efficacy and selectivity, as well as reduced adverse side effects, along with establishing a platform of specific and diversified pre-clinical tests, to inform in turn the resulting clinical investigations.

1 July 2007 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Closed access
NKN. Kassouf
N. Kassouf
AAA. Ambily
A. Ambily
KAKalwant Authi
Kalwant Authi